Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 8.2.2021ALK-Abelló A/S (XLL-DK)69225Soluprick (sol inj 1x2 ml (alergén, kontrola) (liek.inj.skl.))8.2.2021R
 8.2.2021Sandoz GmbH (SAN-A)35716Azithromycin Sandoz 500 mg filmom obalené tablety (tbl flm 6x500 mg (blis.PVC/PVDC/Al))1.3.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)1695CIvabradín Sandoz 7,5 mg (tbl flm 56x7,5 mg (blis.PVC/PE/PVDC/Al))1.3.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)35378Valproát chrono Sandoz 500 mg tablety predľženým uvoľňovaním (tbl plg 100x500 mg (blis.Al/Al))1.3.2021Z
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38291Fentanyl Sandoz 25 µg/h matrix transdermálna náplasť (emp tdm 5x25 µg/1 h)1.3.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)51317Contiroxil 20 mg tablety s predĺženým uvoľňovaním (tbl plg 56x20 mg (blister))1.3.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5442ATelmisartan/Hydrochlorotiazid Sandoz 80 mg/25 mg (tbl obd 28x80 mg/25 mg (blis.Al/Al))1.3.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)58563Ceftriaxon Sandoz 1 g prášok na injekčný a infúzny roztok (plo ijf 5x1x1 g (liek.inj.skl.-15 ml))15.2.2021R
 8.2.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5959AXapimant 10 mg filmom obalené tablety (tbl flm 10x10 mg (blis.PVC/PVDC/Al))1.5.2021Z
 8.2.2021Mylan IRE Healthcare Limited (MYR)49450Gopten 0,5 mg (cps 20x0,5 mg (blis.PVC/PVDC/Al))12.2.2021R
 8.2.2021Mylan IRE Healthcare Limited (MYR)56801KLACID I.V. (plc ifc 1x500 mg (liek.inj.skl.))9.2.2021R
 8.2.2021GlaxoSmithKline Biologicals S.A. (GAG)34905Infanrix hexa, prášok a suspenzia na injekčnú suspenziu (plv inu 10x0,5 ml (10x liek.+10x striek.+20x ihla))8.2.2021O
 8.2.2021Teva B.V. (TEV-NL-4)05161Olanzapin Actavis 5 mg filmom obalené tablety (tbl flm 56x5 mg (blis.Al/Al))15.2.2021R
 5.2.2021ratiopharm GmbH (RAT)38788Trandolapril-ratiopharm 4 mg (cps dur 28x4 mg)22.2.2021R
 5.2.2021Novartis Europharm Limited (NEH-IE)07339Tyverb 250 mg filmom obalené tablety (tbl flm 70x250 mg (fľ.HDPE))5.2.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)